Skip to main content
TipRanks
Go Ultimate75% OFF

InnoCan Pharma (INNPF) Revenue

17 Followers

InnoCan Pharma Revenue

InnoCan Pharma had a revenue of 5.29M in the quarter ending Jun 30, 2026, with -16.89%. This bring the company's revenue in the last twelve months to 23.45M, Decreased 6.83%. In the fiscal year ending Dec 31, 2025, InnoCan Pharma had annual revenue of 26.61M with -9.60% growth.

Revenue (ttm)
23.45M
Revenue Growth
-18.39%
P/S Ratio
0.22
Revenue/Employee
$2,419,273
Employees
11
Market Cap
$5.75M

Revenue Chart

InnoCan Pharma Revenue - Annual

05M10M15M20M25M30M35M8.00K196.00K2.56M13.66M29.44M26.61M20182020202120222022202420252025
Revenue History
Download to Excel
INNPF revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202526.61M-2.83M-9.60%
Mar 31, 202529.44M15.78M115.55%
Mar 31, 202413.66M11.10M433.69%
Dec 31, 20222.56M2.36M1205.61%
Mar 31, 2022196.00K188.00K2350.00%
Mar 31, 20218.00K8.00K―
Mar 31, 20200.000.00―
Dec 31, 20180.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
INNPF23.45M
TSE:ATLE―
TSE:LABS41.46M
TSE:VM50.85K
TSE:AVCN25.31M